In a recent study, Risperdal side effects increased a
patient's chances of developing diabetes by about 50 percent compared to older
antipsychotic drugs prescribed for schizophrenia and bipolar mania.
Janssen Pharmaceutica, part of Johnson & Johnson, misled physicians by
minimizing the health risks of prescribing Risperdal (generic risperdone).
Clinical trials testing Risperdal in Alzheimer patients heightened concerns that
the occurrence of serious Risperdal side effects is higher than previously
thought. Among the 764 Risperdal study participants, 29 cases of stroke and
stroke-related side effects were seen, plus four deaths.
Personal Injury Attorney Disclaimer: This website provides general information about Pennsylvania Risperdal lawsuits and other legal information. Nothing on this site is intended to be legal advice. The materials on this site may be considered advertising. Nothing on this site constitutes the formation of an attorney client relationship. This website is not intended to solicit clients outside the Commonwealth of Pennsylvania. In order to discuss representation, we must personally speak with you and enter into a signed, written agreement for representation. By utilizing this site, you agree to the foregoing.